ALEXANDRIA, Va., July 3 -- United States Patent no. 12,343,327, issued on July 1, was assigned to Cybin UK Ltd (London).
"Injectable formulations" was invented by Marie Claire Layzell (London) and James Maxwell Rennie (London).
According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein are pharmaceutical formulations, methods for their production, and uses thereof. The pharmaceutical formulations comprise a salt of an optionally substituted dimethyltryptamine compound, a buffer, which is separate to the salt, and water. The formulations have pH values of from about 3.5 to about 6.5 and osmolalities of about 250 to about 350 mOsm/Kg. Such formulations are suitable for injection, being both stable and clinic...